wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33404024-28DE7D3C-B8B3-49B3-B311-A68D72BA9CFB
Q33404024-28DE7D3C-B8B3-49B3-B311-A68D72BA9CFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404024-28DE7D3C-B8B3-49B3-B311-A68D72BA9CFB
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours
P2860
Q33404024-28DE7D3C-B8B3-49B3-B311-A68D72BA9CFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404024-28DE7D3C-B8B3-49B3-B311-A68D72BA9CFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c279e1bcb0ca46b02d1fbc1dbe0f9b3680a6914e
P2860
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.